1.53
Precedente Chiudi:
$1.47
Aprire:
$1.65
Volume 24 ore:
2.95M
Relative Volume:
0.25
Capitalizzazione di mercato:
$61.38M
Reddito:
-
Utile/perdita netta:
$-20.34M
Rapporto P/E:
-2.1951
EPS:
-0.697
Flusso di cassa netto:
$-15.59M
1 W Prestazione:
+4.79%
1M Prestazione:
+10.07%
6M Prestazione:
+9.29%
1 anno Prestazione:
-24.63%
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BEAT
Heartbeam Inc
|
1.53 | 58.97M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-31 | Iniziato | Roth Capital | Buy |
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time - Business Wire
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target - Digital Journal
BEAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform - Digital Journal
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Digital Journal
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - USA Today
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - USA Today
Risk On: Is SQNS stock a hidden gemMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn
HeartBeam (BEAT) Price Target Increased by 16.22% to 5.48 - Nasdaq
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - USA Today
Breakout Move: What are HeartBeam Inc Equity Warrants recent SEC filings showingEarnings Growth Report & Smart Money Movement Alerts - baoquankhu1.vn
Will HeartBeam Inc. benefit from rising consumer demand2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform - NewMediaWire
Will HeartBeam Inc. stock attract more institutional investorsWeekly Investment Summary & Smart Swing Trading Techniques - mfd.ru
HeartBeam’s Portable ECG Is Cleared, But Cash Is Tight - Finimize
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software for Assessing Arrhythmia - Diagnostic and Interventional Cardiology
Can HeartBeam Inc. stock deliver consistent earnings growth2025 Technical Overview & Technical Entry and Exit Alerts - mfd.ru
What is HeartBeam Inc.’s book value per shareTreasury Yields & Risk Managed Investment Strategies - mfd.ru
Why HeartBeam Inc. stock is considered a top pickJuly 2025 Institutional & High Accuracy Swing Entry Alerts - mfd.ru
BEAT Should I Buy - Intellectia AI
Jobs Data: Is HeartBeam Inc a turnaround storyPortfolio Update Report & Long-Term Investment Growth Plans - baoquankhu1.vn
HeartBeam (BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Yahoo Finance
Can HeartBeam Inc. outperform in the next rallyTrade Ideas & High Conviction Buy Zone Picks - mfd.ru
Is HeartBeam Inc. a strong candidate for buy and holdSwing Trade & Stepwise Entry and Exit Trade Signals - mfd.ru
What analysts say about HeartBeam Inc. stockJuly 2025 Weekly Recap & Real-Time Market Trend Scan - mfd.ru
Can HeartBeam Inc. Equity Warrant be recession proof2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - mfd.ru
HeartBeam (BEATW) Stock Analysis Report | Financials & Insights - Benzinga
HeartBeam Files $100 Million Mixed Shelf - marketscreener.com
Is HeartBeam Inc. Equity Warrant stock undervalued vs historical averagesWeekly Investment Recap & Real-Time Buy Signal Alerts - mfd.ru
Bryan Humbarger Named Chief Commercial Officer at HeartBeam - Medical Product Outsourcing
Aug Patterns: Can HeartBeam Inc deliver alpha2025 Price Momentum & High Return Trade Guides - baoquankhu1.vn
Market Recap: Does HeartBeam Inc Equity Warrant have pricing powerRecession Risk & Advanced Technical Signal Analysis - baoquankhu1.vn
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Trend Review: Does HeartBeam Inc Equity Warrant have pricing power2025 Earnings Surprises & Detailed Earnings Play Alerts - baoquankhu1.vn
HeartBeam names Bryan Humbarger as CCO - Medical Buyer
US Market Wrap: How volatile is Empire State Realty OP LP Limited Partnership stockJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
HeartBeam appoints Bryan Humbarger as chief commercial officer By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - NewMediaWire
Meme Stocks: Is CTGO on track to beat earningsTrend Reversal & Growth Focused Investment Plans - baoquankhu1.vn
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - 01net
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):